Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Histology After Denosumab Discontinuation
NCT00887965Phase 2Completed
- Sponsor
- Amgen
- Start
- Jun 2009
- Primary completion
- Jun 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of denosumab in osteoporosis, osteopenia, sponsored by Amgen. Started Jun 2009; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00887965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887965.